Andrew Cittadine Monopar Therapeutics (MNPR) insider trading activity

MNPR Quotes by TradingView

Andrew Cittadine is Chief Operating Officer of Monopar Therapeutics. Currently has a direct ownership of 40,938 shares of MNPR, which is worth approximately $1.49 Million. The most recent transaction as insider was on Mar 31, 2023, when has been sold 4,063 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 40.9K
2.68% 3M change
20.92% 12M change
Total Value Held $1.49 Million

Andrew Cittadine Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 31 2023
BUY
Exercise of conversion of derivative security
-
4,063 Added 11.6%
30,957 Common Stock
Dec 31 2022
SELL
Payment of exercise price or tax liability
$3,332 $2.37 p/Share
1,406 Reduced 4.97%
26,894 Common Stock
Dec 31 2022
BUY
Exercise of conversion of derivative security
-
4,062 Added 12.55%
28,300 Common Stock
Nov 15 2022
BUY
Open market or private purchase
$31,500 $3.15 p/Share
10,000 Added 29.21%
24,238 Common Stock
Nov 14 2022
BUY
Open market or private purchase
$18,159 $3.0 p/Share
6,053 Added 29.83%
14,238 Common Stock
Sep 30 2022
SELL
Payment of exercise price or tax liability
$1,810 $1.52 p/Share
1,191 Reduced 12.7%
8,185 Common Stock
Sep 30 2022
BUY
Exercise of conversion of derivative security
-
4,063 Added 30.23%
9,376 Common Stock
Jun 30 2022
SELL
Payment of exercise price or tax liability
$6,468 $2.3 p/Share
2,812 Reduced 34.61%
5,313 Common Stock
Jun 30 2022
BUY
Exercise of conversion of derivative security
-
8,125 Added 50.0%
8,125 Common Stock
AC

Andrew Cittadine

Chief Operating Officer
Wilmette, IL

Track Institutional and Insider Activities on MNPR

Follow Monopar Therapeutics and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells MNPR shares.

Notify only if

Insider Trading

Get notified when an Monopar Therapeutics insider buys or sells MNPR shares.

Notify only if

News

Receive news related to Monopar Therapeutics

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on MNPR